Decreasing Amphetamine-Induced Dopamine Release by Acute Phenylalanine/Tyrosine Depletion: A PET/[11C]Raclopride Study in Healthy Men
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Acute phenylalanine/tyrosine depletion (APTD) has been proposed as a new method to decrease catecholamine neurotransmission safely, rapidly, and transiently. Validation studies in animals are encouraging, but direct evidence in human brain is lacking. In the present study, we tested the hypothesis that APTD would reduce stimulated dopamine (DA) release, as assessed by positron emission tomography (PET) and changes in [(11)C]raclopride binding potential (BP), a measure of DA D2/D3 receptor availability. Eight healthy men received two PET scans, both following d-amphetamine, 0.3 mg/kg, p.o., an oral dose known to decrease [(11)C]raclopride BP in ventral striatum. On the morning before each scan, subjects ingested, in counter-balanced order, an amino-acid mixture deficient in the catecholamine precursors, phenylalanine, and tyrosine, or a nutritionally balanced mixture. Brain parametric images were generated by calculating [(11)C]raclopride BP at each voxel. BP values were extracted from the t-map (threshold: t=4.2, equivalent to p<0.05, Bonferroni corrected) and a priori identified regions of interest from each individual's coregistered magnetic resonance images. Both receptor parametric mapping and region of interest analyses indicated that [(11)C]raclopride binding was significantly different on the two test days in the ventral striatum (peak t=6.31; x=-25, y=-8, and z=0.1). In the t-map defined cluster, [(11)C]raclopride BP values were 11.8+/-11.9% higher during the APTD session (p<0.05). The reduction in d-amphetamine-induced DA release exhibited a linear association with the reduction in plasma tyrosine levels (r=-0.82, p<0.05). Together, the results provide the first direct evidence that APTD decreases stimulated DA release in human brain. APTD may be a suitable new tool for human neuropsychopharmacology research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733 · cited 1×
“Animal studies suggest that this reflects regional differences in drug-induced increases in synaptic DA levels (Di Chiara and Imperato, 1988) rather than an artifact of the PET method.”
BackgroundA nonparametric method for automatic correction of intensity nonuniformity in MRI data
Sled, J. G., Zijdenbos, A. P., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.668698 · Cited by 4,731 · cited 1×
“These volumes were corrected for image intensity nonuniformity (Sled et al, 1998), and linearly and nonlinearly transformed into standardized stereotaxic space (Talairach and Tournoux, 1988) using automated feature matching to the MNI305 template (Collins et al, 1994b; Collins and Evans, 1997).”
MethodAutomatic 3D intersubject registration of MR volumetric data in standardized Talairach space
Collins, D. L., Neelin, P., Peters, T. M., & Evans, A. C. (1994) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199403000-00005 · Cited by 3,431 · cited 2×
“These volumes were corrected for image intensity nonuniformity (Sled et al, 1998), and linearly and nonlinearly transformed into standardized stereotaxic space (Talairach and Tournoux, 1988) using automated feature matching to the MNI305 template (Collins et al, 1994b; Collins and Evans, 1997).”
MethodSimplified Reference Tissue Model for PET Receptor Studies
Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,021 · cited 2×
“Parametric images were generated by calculating [(11)C]raclopride BP (BP1⁄4BAvail/KD; BAvail 1⁄4 density of available receptors) at each voxel, using a simplified reference tissue compartmental model with cerebellar activity as the reference (Lammertsma and Hume, 1996; Gunn et al, 1997).”
MethodThe Family History Method Using Diagnostic Criteria: Reliability and Validity
Andreasen, N. C. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770220111013 · Cited by 1,901 · cited 1×
“None had a first-degree relative history of axis I psychiatric disorders as assessed by Research Diagnostic Criteria for Family Histories (Andreasen et al, 1977).”
MethodDesign and construction of a realistic digital brain phantom
Collins, D. L., Zijdenbos, A. P., Kollokian, V., Sled, J. G., Kabani, N. J., Holmes, C. J., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.712135 · Cited by 1,822 · cited 1×
“First, each tissue type (gray matter, white matter, and CSF) was automatically classified (Collins et al, 1998).”
BackgroundParametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,084 · cited 1×
“Parametric images were generated by calculating [11C]raclopride BP (BP¼BAvail/KD; BAvail ¼ density of available receptors) at each voxel, using a simplified reference tissue compartmental model with cerebellar activity as the reference (Lammertsma and Hume, 1996; Gunn et al, 1997).”
MethodSelf-citationAutomatic 3‐D model‐based neuroanatomical segmentation
Collins, D. L., Holmes, C. J., Peters, T. M., & Evans, A. C. (1995) · Human Brain Mapping · doi:10.1002/hbm.460030304 · Cited by 974
Tryptophan depletion causes a rapid lowering of mood in normal males
Young, S. N., Smith, S. E., Pihl, R. O., & Ervin, F. R. (1985) · Psychopharmacology · doi:10.1007/bf00431803 · Cited by 713 · cited 1×
“The APTD mixture’s composition, preparation, and administration is based on our 100 gm nutritionally balanced mixture with phenylalanine and tyrosine withheld (Young et al, 1985; Leyton et al, 2000b).”
MethodSelf-citation
Research works printed but not linked: 1
- First MB, Spitzer RI, Gibbon M (1995). Axis I Disorders. New York State Psychiatric Institute: New York.
Cited by
Neuroscience of apathy and anhedonia: a transdiagnostic approach
Husain, M., & Roiser, J. P. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0029-9 · Cited by 640
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“Reductions in ligand binding in PET (Boileau et al., 2007; Buckholtz et al., 2010; Cardenas et al., 2004; Cropley et al., 2008; Drevets et al., 2001; Leyton et al., 2002, 2004; Martinez et al., 2003; Narendran et al., 2009, 2010; Oswald et al., 2005, 2015; Riccardi et al., 2006aa,b, 2011; Shotbolt…”
Dopamine, serotonin and impulsivity
Dalley, J. W., & Roiser, J. P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.065 · Cited by 501
“This model may explain why studies using acute tyrosine and phenylalanine depletion, a procedure by which DA synthesis can be decreased by restricting dietary intake of these amino acids (Montgomery et al., 2003; Leyton et al., 2004), have generally not reported reliable effects on any measures of impulsivity (Harmer…”
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Tremblay, L. K., Naranjo, C. A., Graham, S. J., Herrmann, N., Mayberg, H. S., Hevenor, S., & Busto, U. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1228 · Cited by 340
“The link between dextroamphetamineinduced dopamine release and rewarding effects in humans is well established.(16,17,51,52) Therefore, results of this study provide support for the involvement of dopaminergic mechanisms in the altered reward processing in MDD.”
ResultLinking nucleus accumbens dopamine and blood oxygenation
Knutson, B., & Gibbs, S. E. B. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0686-7 · Cited by 337
“For instance, future experiments might combine dopamine depletion or antagonism with stimuli known to elicit fast increases in NAcc BOLD signal (e.g., sexually arousing odors in animals or monetary cues in humans; Ferris et al. 2004; Knutson et al. 2001; Leyton et al. 2004).”
BackgroundBoileau, I., Dagher, A., Leyton, M., Gunn, R. N., Baker, G. B., Diksic, M., & Benkelfat, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1386 · Cited by 305
“There is substantial evidence that an intrasynaptic increase in dopamine translates into a proportional reduction in the binding potential (BP) of [(11)C]raclopride(26) and that decreasing catecholamine neurotransmission increases BP.(27) This imaging modality has been used successfully to demonstrate dopamine release…”
BackgroundInfluentialSelf-citationDopamine depletion impairs frontostriatal functional connectivity during a set-shifting task
Nagano-Saito, A., Leyton, M., Monchi, O., Goldberg, Y. K., He, Y., & Dagher, A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3921-07.2008 · Cited by 222
“, 1999) and humans (Leyton et al., 2004).”
BackgroundSelf-citation(2010) · Springer eBooks · doi:10.1007/978-0-387-89676-2 · Cited by 179
Striatal D1 and D2 signaling differentially predict learning from positive and negative outcomes
Cox, S. M. L., Frank, M. J., Larcher, K. M.-H., Fellows, L. K., Clark, C. A., Leyton, M., & Dagher, A. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2014.12.070 · Cited by 170
“, 2013) and humans (Montgomery et al., 2003; Leyton et al., 2004) have established that this method reduces CSF amine metabolite levels and brain dopamine levels by approximately 30% (Montgomery et al.”
BackgroundSelf-citationConditioned and sensitized responses to stimulant drugs in humans
Leyton, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.027 · Cited by 127
Self-citationLeyton, M., Casey, K. F., Delaney, J. S., Kolivakis, T., & Benkelfat, C. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.6.1619 · Cited by 122
Self-citationCoull, J. T., Hwang, H. J., Leyton, M., & Dagher, A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1258-12.2012 · Cited by 119
“Although APTD is an indirect modulator of DA function, its effects on availability of DA precursors were comparable to prior studies showing reduced DA release in humans (Montgomery et al., 2003; Leyton et al., 2004).”
BackgroundResultInfluentialSelf-citationDopamine Signaling Modulates the Stability and Integration of Intrinsic Brain Networks
Shafiei, G., Zeighami, Y., Clark, C. A., Coull, J. T., Nagano-Saito, A., Leyton, M., Dagher, A., & Mišić, B. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhy264 · Cited by 119
Self-citationReliance on habits at the expense of goal-directed control following dopamine precursor depletion
de Wit, S., Standing, H. R., DeVito, E. E., Robinson, O. J., Ridderinkhof, K. R., Robbins, T. W., & Sahakian, B. J. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2563-2 · Cited by 105
Leyton, M., aan het Rot, M., Booij, L., Baker, G. B., Young, S. N., & Benkelfat, C. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0713 · Cited by 100
Self-citationRoiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., Jones, P. B., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300659 · Cited by 96
“Furthermore, two recent neuroimaging studies using 11C-Raclopride, a D2 ligand displaced by endogenous DA release, have demonstrated increased striatal binding (indicative of reduced DA function) following APTD (Leyton et al, 2003; Montgomery et al, 2003).”
BackgroundInfluentialThe role of dopamine in alcohol self-administration in humans: individual differences
Barrett, S. P., Pihl, R. O., Benkelfat, C., Brunelle, C., Young, S. N., & Leyton, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.01.008 · Cited by 92
“The alcohol administration phase of the study was scheduled to begin 5 h after the AA ingestion to coincide with the time frame of pharmacological and behavioural effects observed in previous APTD studies (e.g., Leyton et al., 2000a, 2004, 2005).”
BackgroundMethodSelf-citationAcute serotonin and dopamine depletion improves attentional control: findings from the Stroop task
Scholes, K. E., Harrison, B. J., O'Neill, B. V., Leung, S., Croft, R. J., Pipingas, A., Phan, K. L., & Nathan, P. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301262 · Cited by 86
“…depletion (ATPD) is a technique which has been shown to selectively decrease dopamine synthesis and release (Jaskiw and Bongiovanni, 2004; Leyton et al, 2004; McTavish et al, 1999a, 2001a, b; Mehta et al, 2005; Montgomery et al, 2003) and impair dopamine dependent cognitive processes…”
MethodO'Neill, B., Croft, R., & Nathan, P. (2008) · Human psychopharmacology · doi:10.1002/hup.940 · Cited by 112
“ATPD is a technique which has been shown to decrease catecholamine synthesis and release, predominantly dopamine (Leyton et al., 2004; McTavish et al., 1999; Mehta et al., 2005; Montgomery et al., 2003), but despite this APTD had no effects on the LDAEP (O’Neill et al., 2008), which supports our…”
Reduced Dopamine Response to Amphetamine in Subjects at Ultra-High Risk for Addiction
Casey, K. F., Benkelfat, C., Cherkasova, M. V., Baker, G. B., Dagher, A., & Leyton, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.033 · Cited by 81
Self-citationVenugopalan, V. V., Casey, K. F., O'Hara, C., O'Loughlin, J., Benkelfat, C., Fellows, L. K., & Leyton, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.135 · Cited by 70
“In previous research, APTD has been demonstrated to decrease striatal DA release induced by d-amphetamine (Leyton et al, 2004).”
BackgroundResultSelf-citationLeung, S., Croft, R. J., Guille, V., Scholes‐Balog, K. E., O’Neill, B. V., Phan, K. L., & Nathan, P. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1723-0 · Cited by 66
Cawley, E., Park, S., aan het Rot, M., Sancton, K., Benkelfat, C., Young, S., Boivin, D., & Leyton, M. (2013) · Journal of Psychiatry & Neuroscience · doi:10.1503/jpn.120181 · Cited by 61
Self-citationHitsman, B. L., MacKillop, J. M., Lingford-Hughes, A. R., Williams, T. A., Ahmad, F., Adams, S. H., Nutt, D. J., & Munafo, M. R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0995-5 · Cited by 63
“Administration of the TYR/PHE-free mixture in humans increases prolactin levels (Harmer et al. 2001) and decreases extracellular dopamine levels, as indexed by changes in [11C]raclopride binding (Leyton et al. 2004; Montgomery et al. 2003).”
MethodStriatal Dopamine Influences the Default Mode Network to Affect Shifting between Object Features
Dang, L. C., Donde, A., Madison, C., O'Neil, J. P., & Jagust, W. J. (2012) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00252 · Cited by 60
“Although our results seem to conflict with this finding, it is important to note that APTD reduces both tonic and phasic dopamine release (Leyton et al., 2004; Montgomery, McTavish, Cowen, & Grasby, 2003), suggesting that the resulting effects on cognition with this method may be more complex (Mehta, Gumaste, Montgome…”
Lack of effect of acute dopamine precursor depletion in nicotine-dependent smokers
Casey, K. F., Benkelfat, C., Young, S. N., & Leyton, M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.02.002 · Cited by 54
Self-citationDopamine Depletion Reduces Food-Related Reward Activity Independent of BMI
Frank, S., Veit, R., Sauer, H., Enck, P., Friederich, H.-C., Unholzer, T., Bauer, U.-M., Linder, K., Heni, M., Fritsche, A., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.313 · Cited by 48
“As anticipated, the DOPD condition resulted in lower caudate activation than the CON condition, which tallies with previous studies (Leyton et al, 2004; Nagano-Saito et al, 2012).”
BackgroundResultNagano-Saito, A., Cisek, P., Perna, A. S., Shirdel, F. Z., Benkelfat, C., Leyton, M., & Dagher, A. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00592.2011 · Cited by 47
“Dopamine transmission was lowered using the acute phenylalanine/tyrosine depletion (APTD) method (Leyton et al. 2000, 2004; Nagano-Saito et al. 2008).”
BackgroundMethodInfluentialSelf-citationRobinson, O. J., Standing, H. R., DeVito, E. E., Cools, R., & Sahakian, B. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1880-1 · Cited by 47
Boot, E., Booij, J., Hasler, G., Zinkstok, J. R., de Haan, L., Linszen, D. H., & van Amelsvoort, T. A. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0739-8 · Cited by 47
Carbonell, F., Nagano‐Saito, A., Leyton, M., Cisek, P., Benkelfat, C., He, Y., & Dagher, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.12.021 · Cited by 52
Self-citationLaruelle, M. A. (2012) · Neuromethods · doi:10.1007/7657_2012_45 · Cited by 47
Mental fatigue-induced decrease in levels of several plasma amino acids
Mizuno, K., Tanaka, M., Nozaki, S., Yamaguti, K., Mizuma, H., Sasabe, T., Sugino, T., Shirai, T., Kataoka, Y., Kajimoto, Y., et al. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0608-1 · Cited by 45
“Plasma amino acid levels are thought to be influenced by brain activities; e.g., a molecular imaging study showed that the plasma level of tyrosine, which is a precursor amino acid of dopamine, was correlated with the extent of neurotransmission (Leyton et al., 2004).”
BackgroundDopamine and food reward: Effects of acute tyrosine/phenylalanine depletion on appetite
Hardman, C. A., Herbert, V., Brunstrom, J. M., Munafo, M. R., & Rogers, P. J. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.12.022 · Cited by 48
“Human studies have shown increased prolactin levels [18] and enhanced [(11)C]raclopride binding (indicating decreased extracellular dopamine levels) [19,20] as a result of the depletion.”
BackgroundMacronutrients and obesity: Revisiting the calories in, calories out framework
Riera‐Crichton, D., & Tefft, N. (2014) · Economics & Human Biology · doi:10.1016/j.ehb.2014.04.002 · Cited by 47
Neural systems for choice and valuation with counterfactual learning signals
Tobia, M. J., Guo, R., Schwarze, U., Böhmer, W., Gläscher, J. P., Finckh, B., Marschner, A., Büchel, C., Obermayer, K., & Sommer, T. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.11.051 · Cited by 41
“Despite these inconsistent behavioral effects of dietary depletion, both DA and 5HT depletion reliably reduce dopaminergic (Leyton et al., 2004; McTavish et al., 1999;Montgomery et al., 2003) and serotonergic (Crockett et al.”
Dowlati, Y., Ravindran, A. V., Segal, Z. V., Stewart, D. E., Steiner, M. S., & Meyer, J. H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611965114 · Cited by 40
“Oral tyrosine administration increases resiliency against stressinduced impairment of cognitive tasks, and depletion of tyrosine induces depressed mood and reduces stimulant-provoked dopamine release in humans and rodents (38, 39, 43, 44).”
BackgroundDopamine precursors depletion impairs impulse control in healthy volunteers
Ramdani, C., Carbonnell, L., Vidal, F., Béranger, C., Dagher, A., & Hasbroucq, T. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3686-z · Cited by 36
“Dopamine depletion Dopamine availability was decreased using the APTDmethod (McTavish et al. 1999a; Leyton et al. 2000, 2004; NaganoSaito et al. 2008, 2012).”
BackgroundMethodResultInfluentialSelf-citationO'Hara, C., Keyes, A., Renwick, B., Leyton, M., Campbell, I. C., & Schmidt, U. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145894 · Cited by 34
“Larger effects are seen under challenge conditions [58], and, in microdialysis studies conducted in rats, stimulated DA release can be decreased by up to 70% [59].”
BackgroundSelf-citationBecker, S., Čeko, M., Louis-Foster, M., Elfassy, N. M., Leyton, M., Shir, Y., & Schweinhardt, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080766 · Cited by 38
“However, similar decreases with the control mixtures have been observed previously [57,62] and are not expected to yield appreciable changes in dopamine synthesis due to near saturation of the rate-limiting enzyme in dopamine synthesis, tyrosine hydroxylase [61,90-92].”
BackgroundSelf-citationHartmann, H., Pauli, L., Janssen, L. K., Hühn, S., Ceglarek, U., & Horstmann, A. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12917 · Cited by 40
Alves, F. D. S., Schmitz, N., Figee, M., Abeling, N. G. G. M., Hasler, G., van der Meer, J. N., Nederveen, A. J., de Haan, L., LINSZEN, D. H., & van Amelsvoort, T. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110367731 · Cited by 36
“…(PET) and single photon emission computed tomography (SPECT) studies have shown that ATPD and AMPT administration decreased dopamine availability in the ventral striatum, a region previously implicated in reward behaviour (Laruelle et al., 1997; Leyton et al., 2004; Montgomery et al., 2003).”
BackgroundKelm, M. K., & Boettiger, C. A. (2013) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00464 · Cited by 32
“Although studies in rats (McTavish, Cowen, & Sharp, 1999) and humans (Leyton et al., 2004) have shown that P/T depletion reduces DA release in the striatum by at least 30%, it is possible that low DA levels in the brainstem may reduce DRD2 receptor-mediated somatodendritic autoinhibition, thereby…”
BackgroundThe “highs and lows” of the human brain on dopaminergics: Evidence from neuropharmacology
Martins, D., Mehta, M. A., & Prata, D. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.003 · Cited by 35
“Grey to increasingly darker green scale represents increasing congruence of a study’s results with the current background literature and knowledge. striatum (Leyton et al., 2004; Montgomery et al., 2003).”
BackgroundMapping the amphetamine-evoked dopamine release in the brain of the Gottingen minipig
Lind, N. M., Olsen, A. K., Moustgaard, A., Jensen, S. B., Jakobsen, S., Hansen, A. K., Arnfred, S. M., Hemmingsen, R. P., Gjedde, A., & Cumming, P. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.08.007 · Cited by 28
Casey, K. F., Cherkasova, M. V., Larcher, K. M.-H., Evans, A. C., Baker, G. B., Dagher, A., Benkelfat, C., & Leyton, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5029-12.2013 · Cited by 29
“This procedure provides a reliable [ 11C]raclopride change signal (Leyton et al., 2002) that can be increased (Boileau et al., 2006) and decreased (Leyton et al., 2004) by experimental manipulations.”
MethodSelf-citationO'Hara, C., Keyes, A., Renwick, B., Giel, K. E., Campbell, I. C., & Schmidt, U. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165104 · Cited by 29
Lack of Effect of Tyrosine Depletion on Mood in Recovered Depressed Women
McTavish, S. F. B., Mannie, Z. N., Harmer, C. J., & Cowen, P. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300665 · Cited by 26
Munafó, M. R., Mannie, Z. N., Cowen, P. J., Harmer, C. J., & McTavish, S. B. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077216 · Cited by 25
“In humans, administration of the TYR-free mixture leads to increases in prolactin levels (Harmer et al., 2001), and decreases in extracellular DA levels, as indexed by changes in [11C]raclopride binding (Leyton et al., 2004; Montgomery et al., 2003).”
BackgroundNeuhaus, A. H., Goldberg, T. E., Hassoun, Y., Bates, J. A., Nassauer, K. W., Sevy, S. M., Opgen‐Rhein, C., & Malhotra, A. K. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.023 · Cited by 25
“A superior approach might be provided by the use of nutritionally balanced amino acid mixtures deficient in tyrosine and phenylalanine and a balanced amino acid mixture as control condition (e.g. Leyton et al., 2004; Nagano-Saito et al., 2004 ).”
Larson, M. J., Clayson, P. E., Primosch, M., Leyton, M., & Steffensen, S. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140770 · Cited by 24
“APTD treatments, therefore, lead to marked reductions in PHE and TYR availability, reducing dopamine synthesis and release in the striatum and areas of the cortex, including the anterior cingulate cortex (ACC) [10, 12, 13, 14, 15].”
BackgroundInfluentialSelf-citationAffective Bias and Response Modulation Following Tyrosine Depletion in Healthy Adults
Vrshek‐Schallhorn, S., Wahlstrom, D., Benolkin, K., White, T. J. H., & Luciana, M. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301172 · Cited by 24
“Similarly, PET scanning during d-amphetamine challenge following ATPD in healthy males resulted in a significant increase in [11C]Raclopride binding (11.8%), suggesting decreased DA release (Leyton et al, 2004).”
BackgroundInfluentialAcute phenylalanine/tyrosine depletion of phasic dopamine in the rat brain
Shnitko, T. A., Taylor, S. C., Stringfield, S. J., Zandy, S. L., Cofresí, R. U., Doherty, J. M., Lynch, W. B., Boettiger, C. A., Gonzales, R. A., & Robinson, D. L. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4259-0 · Cited by 22
“One method currently used to investigate dopamine's role in human behaviors is acute phenylalanine/tyrosine depletion (Moja et al. 1996; Leyton et al. 2000b, 2004).”
BackgroundMethodInfluentialSupport for limited brain availability of tyrosine in patients with schizophrenia
Bjerkenstedt, L., Farde, L., Terenius, L. Y., Edman, G., Venizelos, N., & Wiesel, F. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005638 · Cited by 21
“…plasma levels of tyrosine are related to DA concentration in the brain has received direct experimental support from PET studies in healthy men showing that nutrition with a phenylalanine/tyrosine-free mixture reduces DA release in the human brain (Leyton et al., 2003 ; Montgomery et al., 2003).”
BackgroundEllis, K. A., Mehta, M. A., Wesnes, K. A., Armstrong, S., & Nathan, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0019-2 · Cited by 22
“Indeed, low doses of pergolide can augment motor deficits associated with Parkinson’s disease (Kellett and Steiger 1999), and recent evidence suggests that L-Dopa administration augmented, rather than reversed, TPD-related decreases in cocaine-induced drug craving (Leyton et al. 2004).”
BackgroundElton, A., Faulkner, M. L., Robinson, D. L., & Boettiger, C. A. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00993-9 · Cited by 21
Linssen, A. M. W., Riedel, W. J., & Sambeth, A. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109348160 · Cited by 21
“Indeed, there is evidence that Tyrosine/phenylalanine depletion (TPD) reduces dopamine release, dopamine synthesis and attenuates the induced elevation of dopamine levels (Bongiovanni et al., 2008; Le Masurier et al., 2004b; Leyton et al., 2004; McTavish et al., 1999; Montgomery et al., 2003).”
BackgroundAmino acid challenge and depletion techniques in human functional neuroimaging studies: an overview
Biskup, C. S., Gaber, T. J., Helmbold, K., Bubenzer‐Busch, S., & Zepf, F. D. (2015) · Amino Acids · doi:10.1007/s00726-015-1919-z · Cited by 19
“The dopaminergic system can be modulated in the short term by using ATPD, which reduces striatal DA release (Montgomery et al. 2003; Leyton et al. 2004) and modulates frontostriatal connectivity (Nagano-Saito et al. 2008).”
BackgroundCoull, J. T., Hwang, H. J., Leyton, M., & Dagher, A. (2013) · Timing & Time Perception · doi:10.1163/22134468-00002005 · Cited by 17
Self-citationPreece, M., Sibson, N. R., Raley, J. M., Blamire, A. M., Styles, P., & Sharp, T. (2007) · Synapse · doi:10.1002/syn.20442 · Cited by 18
“…by the tyrosine-free amino acid mixture is consistent with previous in vivo neurochemical and PET imaging studies demonstrating that this same mixture decreases the dopamine releasing effect of amphetamine in caudate nucleus (Le Masurier et al., 2004a; Leyton et al., 2004; McTavish et al., 1999b).”
ResultCognitive flexibility in humans and other laboratory animals
Highgate, Q., & Schenk, S. (2020) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2020.1784240 · Cited by 22
Ellis, K. A., Mehta, M. A., Murthy, P. J. N. V., McTavish, S. F. B., Nathan, P. J., & Grasby, P. M. (2007) · Human Brain Mapping · doi:10.1002/hbm.20339 · Cited by 15
“…brain dopamine [McTavish et al., 1999a,b,c; Milner et al., 1986; Montgomery et al., 2003; Tam and Roth, 1997], with recent evidence that TPD reduces DA levels within the human striatum [Montgomery et al., 2003] and decreases amphetamine-induced DA release within the striatum [Leyton et al., 2004b].”
BackgroundResultCoull, J. T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1782-2_13 · Cited by 14
“This is an amino acid drink deficient in the DA precursors phenylalanine and tyrosine and has been shown to reduce striatal DA release [92, 93].”
BackgroundChassignolle, M., Jovanović, L., Schmidt‐Mutter, C., Behr, G., Giersch, A., & Coull, J. T. (2021) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_01700 · Cited by 16
“APTD is an amino acid drink that lowers levels of the dopamine precursors phenylalanine and tyrosine, and reduces striatal dopamine levels in animals (McTavish, Cowen, & Sharp, 1999) and humans (Leyton et al., 2004; Montgomery, McTavish, Cowen, & Grasby, 2003).”
BackgroundResultInfluentialHartmann, H., Janssen, L. K., Herzog, N., Morys, F., Fängström, D., Fallon, S. J., & Horstmann, A. (2023) · Appetite · doi:10.1016/j.appet.2023.106477 · Cited by 15
Dopamine and response selection: an Acute Phenylalanine/Tyrosine Depletion study
Ramdani, C., Vidal, F., Dagher, A., Carbonnell, L., & Hasbroucq, T. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4846-3 · Cited by 12
Self-citationA Preclinical Study of Casein Glycomacropeptide as a Dietary Intervention for Acute Mania
Liebenberg, N., Jensen, E., Larsen, E. R., Kousholt, B. S., Pereira, V. S., Fischer, C. W., & Wegener, G. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy012 · Cited by 10
“The same depleting AA mixtures have also been shown to inhibit amphetamine-induced manic behavior and DA neurotransmission in humans (McTavish et al., 1999b, 2001b; Leyton et al., 2004) and rats (McTavish et al.”
BackgroundThe effects of acute dopamine depletion on resting-state functional connectivity in healthy humans
Caravaggio, F., Barnett, A. J., Nakajima, S., Iwata, Y., Kim, J., Borlido, C., Mar, W., Gerretsen, P., Remington, G. J., & Graff‐Guerrero, A. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.01.003 · Cited by 10
Macronutrients and obesity: views, news and reviews
Madsen, L., Liaset, B., & Kristiansen, K. (2008) · Future Lipidology · doi:10.2217/17460875.3.1.43 · Cited by 11
“Still, in rats, ingestion of a mixture of branched-chain amino acids and tryptophan has been shown to reduce brain levels of tyrosine and L-DOPA [275], and ingestion of amino acid mixtures deficient in phenylalanine and tyrosine has been shown to acutely reduce catecholamine synthesis in animals [79,276–279] and human…”
BackgroundThe Neurochemistry and Psychopharmacology of Anger
Bond, A. J., & Wingrove, J. (2009) · Springer eBooks · doi:10.1007/978-0-387-89676-2_6 · Cited by 10
Grimes, M., Cameron, J. L., & Fernstrom, J. D. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.015 · Cited by 9
Leyton, M., Pun, V. K., Benkelfat, C., & Young, S. N. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0354 · Cited by 8
Self-citationVrshek‐Schallhorn, S., Wahlstrom, D., White, T. J. H., & Luciana, M. M. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.013 · Cited by 7
“Two PET studies found that striatal binding of the competitive DA agonist [11C]-Raclopride increased by approximately 6% following ATPD, supporting a comparable decrease in DA (Leyton et al., 2004; Montgomery et al., 2003).”
BackgroundDopamine and light: effects on facial emotion recognition
Cawley, E., Tippler, M., Coupland, N. J., Benkelfat, C., Boivin, D. B., Rot, M. A. H., & Leyton, M. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711707 · Cited by 9
“, 1999, 2001), a period at which significant decreases in striatal dopamine release have been observed in positron emission tomography (PET) studies (Leyton et al., 2004; Montgomery et al., 2003).”
BackgroundSelf-citationBalancing excitation and inhibition: The role of neural network dynamics in working memory gating
Herzog, N., Čėsnaitė, E., Steinfath, T. P., Kapralov, N., Fallon, S. J., Nikulin, V., Villringer, A., Janssen, L. K., & Horstmann, A. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00380 · Cited by 7
Age moderates the effect of acute dopamine depletion on passive avoidance learning
Kelm, M. K., & Boettiger, C. A. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.01.014 · Cited by 5
“Although studies in rats (McTavish, Cowen, & Sharp, 1999) and humans (Leyton et al., 2004) show that P/T-depletion reduces DA release in the striatum by 30% or more, lowering DA levels in the brainstem could theoretically reduce DRD2-mediated autoinhibition of DA neurons, thereby increasing DA…”
BackgroundInfluentialChallenge Tests of Monoaminergic Systems: Neurophysiological Aspects
Norra, C. (2007) · Clinical EEG and Neuroscience · doi:10.1177/155005940703800207 · Cited by 6
Working memory gating in obesity is moderated by striatal dopaminergic gene variantsPreprint
Herzog, N., Hartmann, H., Janssen, L. K., Kanyamibwa, A., Waltmann, M., Kovacs, P. L., Deserno, L., Fallon, S. J., Villringer, A., & Horstmann, A. (2024) · eLife · doi:10.7554/elife.93369 · Cited by 9
“This ratio represents the peripheral dopamine precursor availability and can be considered a potential proxy for central dopamine synthesis capacity ( Leyton et al., 2004 ; Montgomery et al., 2003 ).”
The role of dopamine in visual imagery—An experimental pharmacological study
Monzel, M., Karneboge, J., & Reuter, M. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25262 · Cited by 5
“In addition, positron emission tomography studies (Leyton et al., 2004; Montgomery et al., 2003) prove the successful reduction of dopaminergic activity in striatal areas by approximately 10%–20% by means of BCAAs (Montgomery et al., 2003), which has been reliably demonstrated even after the…”
BackgroundBrecht, A.-K., Medawar, E., Thieleking, R., Sacher, J., Beyer, F., Villringer, A., & Witte, A. V. (2022) · Appetite · doi:10.1016/j.appet.2022.106093 · Cited by 3
Imaging in Neurology Research III: Focus on Neurotransmitter Imaging
Schiffer, W. K. (2010) · Springer eBooks · doi:10.1007/978-3-642-12945-2_34 · Cited by 2
Clozapine but not lithium reverses aberrant tyrosine uptake in patients with bipolar disorder
Tabrisi, R., Harun-Rashid, M., Montero, J., Venizelos, N., & Msghina, M. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06397-5 · Cited by 2
Addressing comments by JD Fernstrom
Humphries, P., & Pretorius, E. (2008) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2008.4 · Cited by 1
Cognitive and electrophysiological responses to dopaminergic manipulations
Linssen, A. M. W. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130118al · Cited by 1
Brecht, A.-K., Medawar, E., Thieleking, R., Sacher, J., Beyer, F., Villringer, A., & Witte, A. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.01.470815 · Cited by 1
“Human studies also showed that dietary tyr/protein intake changes serum levels of tyr (J D Fernstrom et al., 1979; Strang et al., 2017; van de Rest et al., 2017; Wurtman et al., 2003), and acute depletion of tyr decreased brain DA measured indirectly using positron emission tomography (PET) (Leyton et al., 2004).”
InfluentialPhenylalanine and Tyrosine Depletion
Leyton, M. (2013) · Springer eBooks · doi:10.1007/978-3-642-27772-6_33-3 · Cited by 1
Self-citationAmino acids and psychiatric disorders : a historical background
Venizelos, N., & Bjerkenstedt, L. (2011)
Balducci, X. L. (2009) · TSpace (University of Toronto) · Cited by 1
Hartmann, H., Pauli, L. K., Janssen, L. K., Hühn, S., Ceglarek, U., & Horstmann, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/839647
Phenylalanine and Tyrosine Depletion
Leyton, M. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_33
Self-citationPhenylalanine and Tyrosine Depletion
Leyton, M. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_33 · Cited by 1
Self-citationWorking memory gating in obesity is moderated by striatal dopaminergic gene variants
Herzog, N., Hartmann, H., Janssen, L. K., Kanyamibwa, A., Waltmann, M., Kovacs, P. L., Deserno, L., Fallon, S. J., Villringer, A., & Horstmann, A. (2024) · eLife · doi:10.1101/2023.11.03.565528 · Cited by 3
Neuro-metabolic pathways of high-protein meal reducing food cravingPreprint
Pu, M., Janet, R., Artigas, S. O., Ulrich, A., Tardu, J., Mohr, P. N. C., Wilms, B., Koletzko, B. V., Meyhoefer, S. M., & Park, S. Q. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.06.697861
Metadata
- Authors
- Leyton, M., Dagher, A., Boileau, I., Casey, K., Baker, G. B., Diksic, M., Gunn, R., Young, S. N., & Benkelfat, C.
- Affiliations
- McGill University (CA)
- University of Alberta (CA)
- Corresponding author
- Leyton, Marco
- Venue
- Neuropsychopharmacology
- Published
- 2003-10-29
- Volume
- 29
- Issue
- 2
- Pages
- 427-432
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1973197910
- Cited by
- 95
- References
- 43
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 4 · 2013: 10 · 2012: 5
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (36429, MOP–36429)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- dopamine release, amphetamine, [11C]raclopride, ventral striatum, plasma tyrosine, catecholamine precursors, amino acid restriction
- MeSH terms
- Adult, Binding Sites, Brain, Brain Mapping, Dextroamphetamine, Dopamine, Drug Interactions, Humans, Male, Phenylalanine, Statistics as Topic, Tomography, Emission-Computed, Tyrosine, Dopamine Antagonists, Diet, Protein-Restricted, Dopamine Uptake Inhibitors, Raclopride
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.